Skip to main content
. 2021 Apr 12;13(8):1834. doi: 10.3390/cancers13081834

Table 3.

Surgical outcomes and late toxicity. For each parameter, if not otherwise specified, the number of patients and, in brackets, the percentage are given. The statistical comparisons were performed using Chi-square test and Kruskal–Wallis test. Please note that the data for surgical complications are missing in 2 patients. Please see Supplemental Table S1 for a detailed list of surgical complications. The data for the hospital and intensive/intermediate care unit stay are missing for 9 patients. The data for late toxicity are missing for 6 patients.

Characteristics 5‑Fluorouracil/
Cisplatin (n = 63)
Carboplatin/
Paclitaxel (n = 27)
p-Value
Surgical outcomes
  Surgical complications 0.43
    Yes 30 (48.4) 15 (57.7)
    No 32 (51.6) 11 (42.3)
  Hospital stay, days, median (min, max) 19 (7–87) 15 (8–140) 0.24
  Intensive/intermediate care unit stay, days, median (min, max) 7 (1–54) 4 (1–115) 0.01
  Death within 30 days post-surgery 1 (1.6) 1 (3.7) 0.53
Late toxicity
  Late dysphagia 0.58
    0 55 (87.3) 18 (85.7)
    1 6 (9.5) 3 (11.1)
    2 2 (3.2) 0
  Dermatitis 0.52
    0 62 (98.4) 27 (100.0)
    1 1 (1.6) 0